Breast Cancer Survival Rates - Breast Cancer Stage 1,2,3 and 4
The Whole Truth and Nothing by The Truth on the Survival Rates
Breast cancer mortality is said to be declining in the United States as well as in other developed and industrialized countries such as Canada, Austria, and the United Kingdom. This is possibly due to the utilization of mammographic screening, other early detection methods of breast cancer, and improvements in therapies.
In contrast however, European nations such as Spain, Portugal, and Italy have not experienced the same declining rate in mortality rates.
On the other hand, the lowest breast cancer mortality rates are in Asia where scientists and researchers speculate that dietary and environmental factors impact the etiology of breast cancer.
Global breast cancer death rates per 100,000 women in the years 1993 to 1995 show Denmark to have the highest at 26.4% compared the United States at 20.7%. Other countries such as Netherlands, United Kingdom, Switzerland, Germany, and Austria, experienced 25.3%, 25.1%, 22.6%, 22.1%, and 21.8% mortality rates respectively. Lowest mortality rates belong to Japan and China with 7.1% and 6.2% respectively.
One of the factors causing differences in mortality rates across different counties is diet. Particularly, researchers proposed that monounsaturated fat consumption is protective while the risk associated to breast cancer is usually attributed to polyunsaturated fat. This is why scientists speculate that countries such as Greece do not have the highest breast cancer mortality rates despite their relatively high fat consumption.
Fortunately, the trend of increasing breast cancer mortality rates in several countries has been reversed. Through disease awareness, continuous availability of screening tests, and modern therapeutic strategies to combating breast cancer, women now have a better chance of surviving breast cancer than before. Further growth and developments in screening, reporting, and therapeutic treatments will surely be helpful in the fight against breast cancer.